Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Howell

Showing results (21-30 of 260) with videos related to

Pageof 26
Sort By:
Cancer Treatment Reports|March 1, 1986
Lack of synergy between cisplatin and cytarabine against ovarian carcinoma in vitroS B Howell, S Gill
Cancer Drug Delivery|January 1, 1985
Intrapericardial instillation of cisplatin in a patient with a large malignant effusionM Markman, S B Howell
Cancer Treatment Reports|June 1, 1983
Preclinical re-evaluation of benzaldehyde as a chemotherapeutic agentR Taetle, S B Howell
Journal of Chromatography|January 22, 1988
Measurement of plasma thiols after derivatization with monobromobimaneS Velury, S B Howell
Cancer Treatment Reports|July 1, 1987
Multivesicular liposomes containing cytarabine entrapped in the presence of hydrochloric acid for intracavitary chemotherapyS Kim, S B Howell
Biochemical Pharmacology|November 1, 1982
Differential toxicity of carrier-bound methotrexate against tumor/bone marrow cells in vivoB C Chu, S B Howell
European Journal of Cancer|November 1, 1980
Achievement of long duration methotrexate exposure with concurrent low dose thymidine protection: influence of methotrexate pharmacokineticsS B Howell, R K Tamerius
Hematology/Oncology Clinics of North America|August 1, 1992
Intraperitoneal therapy in the management of patients with ovarian cancerE F McClay, S B Howell
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Role of hypoxanthine and thymidine in determining methotrexate plus dipyridamole cytotoxicityT C Chan, S B Howell
Cancer Drug Delivery|January 1, 1986
Peritoneal access for intracavitary chemotherapyS B Howell, C E Pfeifle
Pageof 26

Showing results (21-30 of 260) with videos related to

Sort By:
Pageof 26
Cancer Treatment Reports|March 1, 1986
Lack of synergy between cisplatin and cytarabine against ovarian carcinoma in vitroS B Howell, S Gill
Cancer Drug Delivery|January 1, 1985
Intrapericardial instillation of cisplatin in a patient with a large malignant effusionM Markman, S B Howell
Cancer Treatment Reports|June 1, 1983
Preclinical re-evaluation of benzaldehyde as a chemotherapeutic agentR Taetle, S B Howell
Journal of Chromatography|January 22, 1988
Measurement of plasma thiols after derivatization with monobromobimaneS Velury, S B Howell
Cancer Treatment Reports|July 1, 1987
Multivesicular liposomes containing cytarabine entrapped in the presence of hydrochloric acid for intracavitary chemotherapyS Kim, S B Howell
Biochemical Pharmacology|November 1, 1982
Differential toxicity of carrier-bound methotrexate against tumor/bone marrow cells in vivoB C Chu, S B Howell
European Journal of Cancer|November 1, 1980
Achievement of long duration methotrexate exposure with concurrent low dose thymidine protection: influence of methotrexate pharmacokineticsS B Howell, R K Tamerius
Hematology/Oncology Clinics of North America|August 1, 1992
Intraperitoneal therapy in the management of patients with ovarian cancerE F McClay, S B Howell
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Role of hypoxanthine and thymidine in determining methotrexate plus dipyridamole cytotoxicityT C Chan, S B Howell
Cancer Drug Delivery|January 1, 1986
Peritoneal access for intracavitary chemotherapyS B Howell, C E Pfeifle
Pageof 26